Comparing objective wakefulness and vigilance tests to on-the-road driving performance in narcolepsy and idiopathic hypersomnia - Bijlenga D, Urbanus B, van der Sluiszen NNJJM, Overeem S, Ramaekers JG, Vermeeren A, Lammers GJ.
Patients with narcolepsy or idiopathic hypersomnia (IH) are at increased risk of driving accidents. Both excessive daytime sleepiness, i.e. unwanted sleep episodes during the day, and disturbed vigilance are core features of these disorders. We tested on-t... (Source: SafetyLit)
Source: SafetyLit - November 15, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Xywav Gets FDA Approval to Treat Rare Sleep Disorder
FRIDAY, Aug. 13, 2021 -- The drug Xywav has been approved for expanded use in adults with the rare sleep disorder idiopathic hypersomnia, the U.S. Food and Drug Administration said Thursday. It is the first drug to be approved by the FDA for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 13, 2021 Category: Pharmaceuticals Source Type: news

' Date Rape' Drug Gets FDA Approval to Treat Rare Sleep Disorder
FRIDAY, Aug. 13, 2021 -- The drug Xywav has been approved for expanded use in adults with a rare sleep disorder called idiopathic hypersomnia, the U.S. Food and Drug Administration said Thursday. The drug has a checkered history: In the 1960s, it... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 13, 2021 Category: General Medicine Source Type: news

FDA Approves First Drug for Idiopathic Hypersomnia FDA Approves First Drug for Idiopathic Hypersomnia
Xywav, an oral solution of calcium, magnesium, potassium, and sodium oxybates, was approved last year for treating cataplexy or excessive daytime sleepiness in patients with narcolepsy.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 13, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults
DUBLIN, Aug. 12, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 12, 2021 Category: Drugs & Pharmacology Source Type: news

Medications for daytime sleepiness in individuals with idiopathic hypersomnia - Trotti LM, Becker LA, Friederich Murray C, Hoque R.
BACKGROUND: Idiopathic hypersomnia is a disorder of excessive daytime sleepiness, often accompanied by long sleep times or pronounced difficulty in awakening, in the absence of a known cause. The optimal treatment strategy for idiopathic hypersomnia is cur... (Source: SafetyLit)
Source: SafetyLit - May 28, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

On-the-road driving performance of patients with central disorders of hypersomnolence - van der Sluiszen NNJJM, Urbanus B, Lammers GJ, Overeem S, Ramaekers JG, Vermeeren A.
INTRODUCTION: Excessive Daytime Sleepiness is a core symptom of narcolepsy and idiopathic hypersomnia, which impairs driving performance. Adequate treatment improves daytime alertness, but it is unclear whether driving performance completely normalizes. Th... (Source: SafetyLit)
Source: SafetyLit - February 8, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Idiopathic hypersomnia: When 40 winks turns into 48 hours of sleep
Lucy Taylor lives with idiopathic hypersomnia, a rare condition that makes her excessively sleepy. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 29, 2018 Category: Consumer Health News Source Type: news